Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Yierlaifu for prevention of EV71-associated hand, foot and mouth disease
CTR20250508Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of enterovirus 71 vaccine (vero cell), inactivated (2 arms), sponsored by Sinovac Biotech Ltd. Started Sep 2024; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
Beyond the preview
Go deeper on CTR20250508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250508.